Clinical trial
The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and…
NCT00114855 · Oslo University Hospital, Other · Completed
Key facts
| NCT number | NCT00114855 |
|---|---|
| Title | The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose |
| Official title | A Single-Centre, Randomised Double-Blind Placebo-Controlled Study to Measure the Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose |
| Lead sponsor | Oslo University Hospital, Other |
| Collaborators | Pharmalogica Industry Wearnes Biotech @ Medicals Beijing Peking University WBL Biotech Co., Ltd. |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Glucose Metabolism Disorders |
| Intervention type | Drug |
| Interventions | HYPOCOL® |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Jun 20, 2005 |
| Last update posted | Jul 6, 2011 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: